Literature DB >> 7998114

Review of CTLA4Ig use for allograft immunosuppression.

H Lin1, R Q Wei, D Gordon, P Linsley, L A Turka, S F Bolling.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7998114

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

Review 1.  Experimental corneal allograft rejection.

Authors:  Bryan M Gebhardt; Weiyun Shi
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Assessment of dose proportionality, absolute bioavailability, and immunogenicity response of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following subcutaneous and intravenous administration to rats.

Authors:  N R Srinivas; W C Shyu; R S Weiner; G Warner; C Comereski; L K Tay; D S Greene; R H Barbhaiya
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.